Overgaard, R., Ingwersen, S., & Tornøe, C. (2015). Establishing Good Practices for Exposure-Response Analysis of Clinical Endpoints in Drug Development. CPT: Pharmacometrics & Systems Pharmacology, 4(10), 565. https://doi.org/10.1002/psp4.12015
Chicago Style (17th ed.) CitationOvergaard, RV, SH Ingwersen, and CW Tornøe. "Establishing Good Practices for Exposure-Response Analysis of Clinical Endpoints in Drug Development." CPT: Pharmacometrics & Systems Pharmacology 4, no. 10 (2015): 565. https://doi.org/10.1002/psp4.12015.
MLA (9th ed.) CitationOvergaard, RV, et al. "Establishing Good Practices for Exposure-Response Analysis of Clinical Endpoints in Drug Development." CPT: Pharmacometrics & Systems Pharmacology, vol. 4, no. 10, 2015, p. 565, https://doi.org/10.1002/psp4.12015.